• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

约旦人群中的 UDP-葡糖醛酸基转移酶 1A4(UGT1A4)多态性。

UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population.

机构信息

Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan.

出版信息

Mol Biol Rep. 2012 Jul;39(7):7763-8. doi: 10.1007/s11033-012-1615-y. Epub 2012 Feb 25.

DOI:10.1007/s11033-012-1615-y
PMID:22367373
Abstract

Glucuronidation is one of the most important phase II metabolic pathways. It is catalyzed by a family of UDP-glucuronosyltransferase enzymes (UGTs). One of the subfamilies is UGT1A. Allele frequencies in UGT1A4 differ among ethnic groups. The aim of this study was to determine the allelic frequency of two most common defective alleles: UGT1A42 and UGT1A43 in a Jordanian population. A total of 216 healthy Jordanian Volunteers (165 males and 51 females) were included in this study. Genotyping for UGT1A41, UGT1A42 and UGT1A43 was done using a well established polymerase chain reaction-restriction fragment length polymorphism test. Among 216 random individuals studied for UGT1A42 mutation there were 26 individuals who were heterozygous, giving a prevalence of 12% and an allele frequency of 6.5%. Only one individual was homozygous for UGT1A42. The UGT1A43 mutation was detected as heterozygous in 9 of 216 individuals indicating a prevalence of 4.2% and allele frequency of 3.5%. Three individuals were homozygous for the UGT1A43 indicating a prevalence of 1.4%. The prevalence of UGT1A42 is similar to the Caucasians but different from other populations whilst the UGT1A4*3 prevalence in the Jordanian population is distinct from other populations. Our results provide useful information for the Jordanian population and for future genotyping of Arab populations in general.

摘要

葡萄糖醛酸化是最重要的 II 相代谢途径之一。它由一组 UDP-葡萄糖醛酰基转移酶(UGTs)催化。其中一个亚家族是 UGT1A。UGT1A4 的等位基因频率在不同种族之间存在差异。本研究旨在确定约旦人群中两种最常见的缺陷等位基因 UGT1A42 和 UGT1A43 的等位基因频率。本研究共纳入 216 名健康的约旦志愿者(165 名男性和 51 名女性)。使用经过验证的聚合酶链反应-限制性片段长度多态性试验对 UGT1A41、UGT1A42 和 UGT1A43 进行基因分型。在 216 名随机研究 UGT1A42 突变的个体中,有 26 名个体为杂合子,患病率为 12%,等位基因频率为 6.5%。仅有 1 名个体为 UGT1A42 纯合子。在 216 名个体中,UGT1A43 突变被检测为杂合子,患病率为 4.2%,等位基因频率为 3.5%。有 3 名个体为 UGT1A43 纯合子,患病率为 1.4%。UGT1A42 的患病率与白种人相似,但与其他人群不同,而约旦人群中 UGT1A4*3 的患病率与其他人群不同。我们的研究结果为约旦人群提供了有用的信息,也为未来一般阿拉伯人群的基因分型提供了参考。

相似文献

1
UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population.约旦人群中的 UDP-葡糖醛酸基转移酶 1A4(UGT1A4)多态性。
Mol Biol Rep. 2012 Jul;39(7):7763-8. doi: 10.1007/s11033-012-1615-y. Epub 2012 Feb 25.
2
Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population.约旦人群中 UGT1A1 和 UGT1A7 多态性的种族间差异。
Curr Drug Metab. 2019;20(5):399-410. doi: 10.2174/1389200220666190528085151.
3
Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study.ESR1、ESR2、HER2、UGT1A4 和 UGT2B7 多态性与约旦乳腺癌的关联:一项病例对照研究。
BMC Cancer. 2019 Dec 30;19(1):1257. doi: 10.1186/s12885-019-6490-7.
4
Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.墨西哥梅斯蒂索人和西班牙人群中 UGT1A4 基因多态性的种族间差异。
Mol Biol Rep. 2013 Apr;40(4):3187-92. doi: 10.1007/s11033-012-2393-2. Epub 2013 Jan 1.
5
Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants.奥氮平代谢及 UGT1A448V 和 UGT2B1067Y 变异体的意义。
Pharmacogenet Genomics. 2011 Sep;21(9):539-51. doi: 10.1097/FPC.0b013e328348c76b.
6
Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.UGT1A4 启动子 SNP 在阿那曲唑药物基因组学中的潜在作用。
Drug Metab Dispos. 2013 Apr;41(4):870-7. doi: 10.1124/dmd.112.048157. Epub 2013 Jan 31.
7
Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.肝脏葡萄糖醛酸化作用的变异:尿苷二磷酸葡萄糖醛酸基转移酶UGT1A4的新型功能多态性
Hepatology. 2004 Apr;39(4):970-7. doi: 10.1002/hep.20131.
8
Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine.UGT1A4*2(P24T)和*3(L48V)的频率及其对拉莫三嗪血清浓度的影响。
Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):149-55. doi: 10.1007/s13318-014-0247-0. Epub 2014 Dec 10.
9
UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation.
Drug Metab Dispos. 2005 May;33(5):672-5. doi: 10.1124/dmd.104.002576. Epub 2005 Feb 11.
10
Glucuronidation of the second-generation antipsychotic clozapine and its active metabolite N-desmethylclozapine. Potential importance of the UGT1A1 A(TA)₇TAA and UGT1A4 L48V polymorphisms.第二代抗精神病药氯氮平及其活性代谢物 N-去甲基氯氮平的葡萄糖醛酸化。UGT1A1 A(TA)₇TAA 和 UGT1A4 L48V 多态性的潜在重要性。
Pharmacogenet Genomics. 2012 Aug;22(8):561-76. doi: 10.1097/FPC.0b013e328354026b.

引用本文的文献

1
Analysis of Comprehensive Pharmacogenomic Profiling of VIP Variants Among the Genetically Isolated Chechen Subpopulation from Jordan.约旦基因隔离的车臣亚人群中VIP变体的综合药物基因组学分析
Pharmgenomics Pers Med. 2020 Jul 14;13:199-215. doi: 10.2147/PGPM.S254677. eCollection 2020.
2
The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension.遗传多态性 UGT1A4*3 与接受口服混悬剂的血液恶性肿瘤患者中较低的泊沙康唑血浆浓度相关。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.02230-17. Print 2018 Jul.
3

本文引用的文献

1
The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.伊朗南部人群中巯嘌呤 S-甲基转移酶等位基因的频率和分布。
Mol Biol Rep. 2012 Apr;39(4):4581-7. doi: 10.1007/s11033-011-1248-6. Epub 2011 Sep 22.
2
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.CYP3A5 和 ABCB1 基因多态性及其他因素对高加索肝、肾移植患者他克莫司剂量的影响。
Int J Mol Med. 2011 Dec;28(6):1093-102. doi: 10.3892/ijmm.2011.794. Epub 2011 Sep 12.
3
Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole.
Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
采用非线性混合效应模型研究丙戊酸与拉莫三嗪联用在中国癫痫儿童中的群体药代动力学。
Eur J Clin Pharmacol. 2018 May;74(5):583-591. doi: 10.1007/s00228-018-2414-8. Epub 2018 Jan 16.
4
Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.丙戊酸浓度及UGT1A4*3、UGT2B7 -161C>T和UGT2B7*2基因多态性对中国癫痫儿童拉莫三嗪血药浓度的影响
Eur J Clin Pharmacol. 2015 Nov;71(11):1341-7. doi: 10.1007/s00228-015-1925-9. Epub 2015 Aug 26.
5
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?拉莫三嗪治疗后出现皮疹和多器官功能障碍:可能与基因有关吗?
Int J Clin Pharm. 2015 Oct;37(5):682-6. doi: 10.1007/s11096-015-0158-4. Epub 2015 Jul 15.
6
Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four open-label, crossover pharmacokinetic trials in healthy volunteers.对乙酰氨基酚与去氧肾上腺素联合给药提高去氧肾上腺素的生物利用度:四项健康志愿者开放标签、交叉药代动力学试验的结果
Eur J Clin Pharmacol. 2015 Feb;71(2):151-8. doi: 10.1007/s00228-014-1788-5. Epub 2014 Dec 6.
7
Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China.中国北方汉族人群中UGT1A4基因多态性与拉莫三嗪血清浓度及治疗效果的相关性
Eur J Clin Pharmacol. 2014 Aug;70(8):941-6. doi: 10.1007/s00228-014-1690-1. Epub 2014 May 13.
8
Interpatient variability in dexmedetomidine response: a survey of the literature.右美托咪定反应的患者间变异性:文献综述
ScientificWorldJournal. 2014 Jan 16;2014:805013. doi: 10.1155/2014/805013. eCollection 2014.
9
Pharmacogenetics of chronic pain and its treatment.慢性疼痛及其治疗的药物遗传学。
Mediators Inflamm. 2013;2013:864319. doi: 10.1155/2013/864319. Epub 2013 May 20.
10
Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.墨西哥梅斯蒂索人和西班牙人群中 UGT1A4 基因多态性的种族间差异。
Mol Biol Rep. 2013 Apr;40(4):3187-92. doi: 10.1007/s11033-012-2393-2. Epub 2013 Jan 1.
约旦人群 CYP2C19 基因多态性:CYP2C19*1 和 CYP2C19*2 等位基因频率对兰索拉唑药代动力学特征的影响。
Mol Biol Rep. 2012 Apr;39(4):4195-200. doi: 10.1007/s11033-011-1204-5. Epub 2011 Jul 17.
4
Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population.香豆素剂量的药物遗传学:黎巴嫩人群中CYP2C9和VKORC1基因多态性的患病率
Genet Test Mol Biomarkers. 2011 Nov;15(11):827-30. doi: 10.1089/gtmb.2010.0248. Epub 2011 Jun 8.
5
Study the polymorphism of CYP3A5 and CYP3A4 loci in Iranian population with laryngeal squamous cell carcinoma.研究伊朗喉鳞癌患者 CYP3A5 和 CYP3A4 基因座的多态性。
Mol Biol Rep. 2011 Nov;38(8):5443-8. doi: 10.1007/s11033-011-0699-0. Epub 2011 Mar 6.
6
Prevalence of CYP2C19 polymorphisms in the Lebanese population.黎巴嫩人群中 CYP2C19 多态性的流行情况。
Mol Biol Rep. 2011 Nov;38(8):5449-52. doi: 10.1007/s11033-011-0700-y. Epub 2011 Mar 5.
7
Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients.CYP3A5基因分型对确定中国肾移植受者他克莫司初始剂量的价值。
Transplant Proc. 2010 Nov;42(9):3459-64. doi: 10.1016/j.transproceed.2010.06.028.
8
Effects of UDP-glucuronosyltransferase polymorphisms on the pharmacokinetics of ezetimibe in healthy subjects.UGT 多态性对健康受试者中依折麦布药代动力学的影响。
Eur J Clin Pharmacol. 2011 Jan;67(1):39-45. doi: 10.1007/s00228-010-0899-x. Epub 2010 Sep 24.
9
Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.约旦人群巯基嘌呤甲基转移酶多态性的遗传分析。
Eur J Clin Pharmacol. 2010 Oct;66(10):999-1003. doi: 10.1007/s00228-010-0826-1. Epub 2010 Jun 3.
10
A pharmacogenetics study of the human glucuronosyltransferase UGT1A4.人类葡萄糖醛酸基转移酶 UGT1A4 的药物遗传学研究。
Pharmacogenet Genomics. 2009 Dec;19(12):945-54. doi: 10.1097/FPC.0b013e3283331637.